ARCA biopharma Inc

Market cap: $46,838,692

Exchange: NAS

Sector: Health Technology

Share
Tweet

ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.

Key Statistics

Company Name

ARCA biopharma Inc

Average Volume (10 days)

749,433

Average Volume (30 days)

4,544,287

Moving Average (50 days)

$2.05

Moving Average (200 days)

$1.85

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

0

Market Cap

46,838,692

Shares Outstanding

14,501,143

52-Week High Split Adjust Only

3.88

52-Week Low Split Adjust Only

1.56

Employee Count

21

Beta

0.3769

Next Earnings Date

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

0.05%

Past 30 days

0.95%

Past 3 months

0.98%

Past 6 months

0.59%

Past year

0.62%

Past 2 years

0.37%

Past 5 years

-0.46%

Max % Change

-0.19%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
ARCA biopharma IncABIOn/an/an/an/an/a
Peer AvgN/A-183.147.687.8-183.14-74.37
Medtronic PlcMDT6.113.3622.36.116.67
United Therapeutics CorpUTHR5.532.4217.45.534.91
Cytokinetics IncCYTK26.7523.08-8.426.7521.82
Palatin Technologies Inc.PTN-770.941.86n/a-770.94-330.89